يعرض 1 - 20 نتائج من 2,345 نتيجة بحث عن '"ПОКОЛЕНИЯ"', وقت الاستعلام: 0.51s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Conference

    المصدر: "XXI ASRDA INNOVATSION TEXNOLOGIYALAR, FAN VA TAʼLIM TARAQQIYOTIDAGI DOLZARB MUAMMOLAR" nomli respublika ilmiy-amaliy konferensiyasi, 2(6), 28-31, (2024-06-07)

  4. 4
    Academic Journal
  5. 5
    Academic Journal

    المساهمون: The study was carried out with the financial support of the Russian Science Foundation (grant No. 22-15-00304)., Исследование выполнено при финансовой поддержке Российского научного фонда (грант № 22-15-00304).

    المصدر: Advances in Molecular Oncology; Том 11, № 3 (2024); 68-78 ; Успехи молекулярной онкологии; Том 11, № 3 (2024); 68-78 ; 2413-3787 ; 2313-805X

    وصف الملف: application/pdf

    Relation: https://umo.abvpress.ru/jour/article/view/709/362; Herbst R.S. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 2004;59(2):21–6. DOI:10.1016/j.ijrobp.2003.11.041; Hynes N.E., Lane H.A. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 2005;5(5):341–54. DOI:10.1038/nrc1609; Jones S., Rappoport J.Z. Interdependent epidermal growth factor receptor signalling and trafficking. Int J Biochem Cell Biol 2014;51:23–8. DOI:10.1016/j.biocel.2014.03.014; Sigismund S., Avanzato D., Lanzetti L. Emerging functions of the EGFR in cancer. Mol Oncol 2018;12(1):3–20. DOI:10.1002/1878-0261.12155; Dreux A.C., Lamb D.J., Modjtahedi H., Ferns G.A. The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis. Atherosclerosis 2006;186(1):38–53. DOI:10.1016/j.atherosclerosis.2005.06.038; Saadeh F.S., Mahfouz R., Assi H.I. EGFR as a clinical marker in glioblastomas and other gliomas. Int J Biol Markers 2018;33(1): 22–32. DOI:10.5301/ijbm.5000301; Brennan C.W., Verhaak R.G., McKenna A. et al. TCGA Research Network. The somatic genomic landscape of glioblastoma. Cell 2013;155(2):462–77. DOI:10.1016/j.cell.2013.09.034; HigaN., AkahaneT., Hamada T. et al Distribution and favorable prognostic implication of genomic EGFR alterations in IDH-wildtype glioblastoma. Cancer Med 2023;12(1):49–60. DOI:10.1002/cam4.4939; Louis D.N., Perry A., Wesseling P. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 2021;23(8):1231–51. DOI:10.1093/neuonc/noab106; Gan H.K., Cvrljevic A.N., Johns T.G. The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered. FEBS J 2013;280(21):5350–70. DOI:10.1111/febs.12393; Eskilsson E., Rosland G.V., Talasila K.M. et al. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. Neuro Oncol 2016;18(12):55. DOI:10.1093/neuonc/now113; Alnahhas I., Rayi A., Guillermo Prieto Eibl M.D.P. et al. Prognostic implications of epidermal and platelet-derived growth factor receptor alterations in 2 cohorts of IDH wt glioblastoma. Neurooncol Adv 2021;3(1):vdab127. DOI:10.1093/noajnl/vdab127; Li J., Liang R., Song C. et al. Prognostic significance of epidermal growth factor receptor expression in glioma patients. Onco Targets Ther 2018;2018(11):731–42. DOI:10.2147/OTT.S155160; Hovinga K.E., McCrea H.J., Brennan C. et al. EGFR amplification and classical subtype are associated with a poor response to bevacizumab in recurrent glioblastoma. J Neurooncol 2019;142(2):337–45. DOI:10.1007/s11060-019-03102-5; Le Rhun E., Preusser M., Roth P. et al. Molecular targeted therapy of glioblastoma. Cancer Treat Rev 2019;80:101896. DOI:10.1016/j.ctrv.2019.101896; Vivanco I., Robins H.I., Rohle D. et al. Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Discov 2012;2(5):458–71. DOI:10.1158/2159-8290.CD-11-0284; Desai R., Suryadevara C.M., Batich K.A. et al. Emerging immunotherapies for glioblastoma. Expert Opin Emerg Drugs 2016;21(2):133–45. DOI:10.1080/14728214.2016.1186643; Weller M., Butowski N., Tran D.D. et al. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. Lancet Oncol 2017;18(10):1373–85. DOI:10.1016/S1470-2045(17)30517-X; Felsberg J., Hentschel B., Kaulich K. et al. German Glioma Network. Epidermal growth factor receptor variant III (EGFRvIII) positivity in EGFR-amplified glioblastomas: prognostic role and comparison between primary and recurrent tumors. Clin Cancer Res 2017;23(22):6846–55. DOI:10.1158/1078-0432.CCR-17-0890; Краснов Г.С., Гукасян Л.Г., Абрамов И.С., Наседкина Т.В. Определение субклональной структуры опухоли по данным высокопроизводительного секвенирования на примере острого миелоидного лейкоза у детей и акральной меланомы. Молекулярная биология 2021;55(5):829–45. DOI:10.31857/S0026898421050050; Chang M.T., Asthana S., Gao S.P. et al. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat Biotechnol 2016;34(2):155–63. DOI:10.1038/nbt.3391; Naidoo J., Sima C.S., Rodriguez K. et al. Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: clinical outcomes and response to erlotinib. Cancer 2015;121(18):3212–20. DOI:10.1002/cncr.29493; The cBio Cancer Genomics Portal. https://www.cbioportal.org/.; Zacher A., Kaulich K., Stepanow S. et al. Molecular diagnostics of gliomas using next generation sequencing of a glioma-tailored gene panel. Brain Pathol 2017;27(2):146–59. DOI:10.1111/bpa.12367; Blobner J., Dengler L., Blobner S. et al. Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma. Neurooncol Adv 2023;5(1):vdad060. DOI:10.1093/noajnl/vdad060; Rutkowska A., Strózik T., Jędrychowska-Dańska K. et al. Immunohistochemical detection of EGFRvIII in glioblastoma – anti-EGFRvIII antibody validation for diagnostic and CAR-T purposes. Biochem Biophys Res Commun 2023;685:149133. DOI:10.1016/j.bbrc.2023.149133; Padovan M., Maccari M., Bosio A. et al. Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis. Eur J Cancer 2023;191:112959. DOI:10.1016/j.ejca.2023.112959; Li J., Liang R., Song C. et al. Prognostic significance of epidermal growth factor receptor expression in glioma patients. Onco Targets Ther 2018;11:731–42. DOI:10.2147/OTT.S155160; Yang K., Ren X., Tao L. et al. Prognostic implications of epidermal growth factor receptor variant III expression and nuclear translocation in Chinese human gliomas. Chin J Cancer Res 2019;31(1):188–202. DOI:10.21147/j.issn.1000-9604.2019.01.14; Begagić E., Pugonja R., Bečulić H. et al. Molecular targeted therapies in glioblastoma multiforme: a systematic overview of global trends and findings. Brain Sci 2023;13(11):1602. DOI:10.3390/brainsci13111602; An Z., Aksoy O., Zheng T. et al. Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene 2018;37(12):1561–75. DOI:10.1038/s41388-017-0045-7; Hegi M.E., Diserens A.C., Bady P. et al. Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib – a phase II trial. Mol Cancer Ther 2011;10(6):1102–12. DOI:10.1158/1535-7163.MCT-11-0048; Hu C., Leche C.A., Kiyatkin A. et al. Glioblastoma mutations alter EGFR dimer structure to prevent ligand bias. Nature 2022;602(7897):518–22. DOI:10.1038/s41586-021-04393-3; Nathanson D.A., Gini B., Mottahedeh J. et al. Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. Science 2014;343(6166):72–6. DOI:10.1126/science.1241328; https://umo.abvpress.ru/jour/article/view/709

  6. 6
    Academic Journal

    المؤلفون: Simonyan, Hamlet

    المصدر: Bulletin of Yerevan University E: Philosophy, Psychology; Vol. 15 No. 3 (45) (2024); 48-60 ; Բանբեր Երևանի համալսարանի. Փիլիսոփայություն, Հոգեբանություն; Vol. 15 No. 3 (45) (2024); 48-60 ; Вестник Ереванского Университета: Философия, Психология ; Том 15 № 3 (45) (2024); 48-60 ; 2738-2621 ; 1829-4553 ; 10.46991/BYSU:E/2024.15.3

    وصف الملف: application/pdf

  7. 7
    Academic Journal

    المصدر: Psychological and Pedagogical Research – Tula Region; ; Психолого-педагогические исследования – Тульскому региону

    وصف الملف: text/html

    Relation: info:eu-repo/semantics/altIdentifier/isbn/978-5-907830-36-3; https://phsreda.com/e-articles/10611/Action10611-111941.pdf; Ануфриев А.Ф. Как преодолеть трудности в обучении детей. Психодиагностические таблицы. Психодиагностические методики. Коррекционные упражнения / А.Ф. Ануфриев, С.Н. Костромина. – М.: Ось-89, 1997. – 224 с.; Бугрименко Е.А. К вопросу о развитии произвольности поведения в дошкольном возрасте / Е.А. Бугрименко // Новые исследования в психологии. – 1978. – №1. – С. 32–37; №2. – С. 69–75.; Волков Б.С. Закономерности психического развития детей в вопросах и ответах / Б.С. Волков, Н.В. Волкова. – М.: Сфера, 2003.; Ермолаев О.Ю. Внимание школьника / О.Ю. Ермолаев, Т.М. Марютина, Т.А. Мешкова. М.: Знание, 1987. – 80 с.; Зейгарник Б.В. Саморегуляция поведения в норме и патологии / Б.В. Зейгарник, А.Б. Холмогоров, Е.С. Мазур // Психологический журнал. – 1989. – №2. – С. 122–132. – EDN POJELZ; Пидкасистый П.И. Самостоятельная познавательная деятельность школьников в обучении / П.И. Пидкасистый. – М.: Просвещение, 1980. – 240 с.; Подпункт 5.2.41 Положения о Министерстве образования и науки Российской Федерации, утвержденного постановлением Правительства Российской Федерации от 3 июня 2013 г. №466.; Рубинштейн С.Л. Основы общей психологии / С.Л. Рубинштейн; Акад. пед. наук СССР. – В 2 т. – М.: Педагогика, 1989. – EDN YWVSOJ; Селевко Г.К. Энциклопедия образовательных технологий / Г.К. Селевко. – В 2 т. Т. 1. – М.: Народное образование, 2005.; Тихомирова Л.Ф. Развитие познавательных способностей детей / Л.Ф. Тихомирова. – Ярославль: Академия развития, 1996. – 192 с. – EDN BLEUZN; Педагогика: теория и методика воспитания: учебник / под ред. Л.В. Мардахаева. – 2014.; Педагогика: учебник / под ред. заслуженного деятеля науки РФ, член-корреспондента РАО, д-ра пед. наук, профессора П.И. Пидкасистого. – 2006. – 332 с.; Энциклопедия для детей. – Т. 18. Человек. Ч. 2. Архитектура души. Психология личности. Мир взаимоотношений. Психотерапия / гл. ред. В. Володин. – М.: Аванта+, 2003. – 640 с.; https://phsreda.com/files/Books/10611/Cover-10611.jpg?req=111941; https://phsreda.com/article/111941/discussion_platform

  8. 8
    Academic Journal

    المصدر: University as a factor of Modernization of Russia: History and Prospects (to the 55th anniversary of the I.N. Ulyanov ChSU); ; Великая Отечественная война в истории народов Поволжья

    وصف الملف: text/html

    Relation: https://phsreda.com/e-articles/10575/Action10575-110519.pdf; Алатырские вести. – 2015. – №18.; Информационный сервис «Подвиг народа в Великой Отечественной войне 1941–1945 гг.» [Электронный ресурс]. Режим доступа: https://podvignaroda.ru (дата обращения: 10.01.2022).; Лукишин А.В. Увековечивание памяти участников Великой Отечественной войны 1941–1945 гг. с использованием современных информационных технологий / А.В. Лукишин, С.А. Лукишина, Е.В. Турайкина // Развитие территориальных социально-экономических систем: матер. межд. науч.-практ. конф. / Чувашский государственный университет имени И.Н. Ульянова, 2020. – С. 27–33. EDN SPIRHC; Память. – Ч. 2. Т. 5 (Российская Федерация, Чувашская Республика). – Чебоксары: Чуваш. кн.изд-во, 2007. – 447 с.; Центральный архив Министерства обороны. – Ф. 33. – Оп. 690306. – Ед. хр. 1971. – № записи: 42847692.; https://phsreda.com/files/Books/10575/Cover-10575.jpg?req=110519; https://phsreda.com/article/110519/discussion_platform

  9. 9
    Academic Journal

    المصدر: Digitalization in the education system: best practices and implementation practices; 137-139 ; Цифровизация в системе образования: передовой опыт и практика внедрения; 137-139

    وصف الملف: text/html

    Relation: info:eu-repo/semantics/altIdentifier/isbn/978-5-907830-18-9; https://phsreda.com/e-articles/10598/Action10598-110955.pdf; Единая Россия [Электронный ресурс]. – Режим доступа: https://clck.ru/39x84h (дата обращения: 08.04.2024).; Мандель Б.Р. Андрагогика: история и современность, теория и практика: учеб.пособие для обучающихся в магистратуре / Б.Р. Мандель. – М.; Берлин: Директ-Медиа, 2017. – 412 с.; Рязанский государственный медицинский университет имени академика И.П. Павлова [Электронный ресурс]. – Режим доступа: https://www.rzgmu.ru/news/2023/07/6853/ (дата обращения: 08.04.2024).; https://phsreda.com/files/Books/10598/Cover-10598.jpg?req=110955; https://phsreda.com/article/110955/discussion_platform

  10. 10
    Academic Journal

    وصف الملف: application/pdf

    Relation: Образование и наука. 2024. № 3; Мерзлякова, С. В. Семейная адаптация как предиктор семейного самоопределения студентов цифрового поколения / С. В. Мерзлякова, Е. П. Каюмова // Образование и наука. — 2024. — № 3. — С. 123–148. — DOI:10.17853/1994-5639-2024-3-123-148.; https://elar.rsvpu.ru/handle/123456789/44059

  11. 11
    Academic Journal

    المصدر: Meditsinskiy sovet = Medical Council; № 6 (2024); 98-111 ; Медицинский Совет; № 6 (2024); 98-111 ; 2658-5790 ; 2079-701X

    وصف الملف: application/pdf

    Relation: https://www.med-sovet.pro/jour/article/view/8273/7295; Asa SL, Kucharczyk W, Ezzat S. Pituitary acromegaly: not one disease. Endocr Relat Cancer. 2017;24(3):C1–C4. https://doi.org/10.1530/erc-16-0496.; Lenders NF, Earls PE, Inder WJ, McCormack AI. The evolution in pituitary tumour classification: a clinical perspective. Endocr Oncol. 2023;3(1):e220079. https://doi.org/10.1530/EO-22-0079.; Asa SL. Challenges in the Diagnosis of Pituitary Neuroendocrine Tumors. Endocr Pathol. 2021;32(2):222–227. https://doi.org/10.1007/s12022-021-09678-x.; Lee CH. Pituitary Neuroendocrine Tumor: Is It Benign or Malignant? Brain Tumor Res Treat. 2023;11(3):173–176. https://doi.org/10.14791/btrt.2023.0015.; Mete O, Wenig BM. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms. Head Neck Pathol. 2022;16(1):123–142. https://doi.org/10.1007/s12105-022-01435-8.; Swanson AA, Erickson D, Donegan DM, Jenkins SM, Van Gompel JJ, Atkinson JLD et al. Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly. Pituitary. 2021;24(2):192–206. https://doi.org/10.1007/s11102-020-01096-2.; Mete O, Asa SL. Structure, Function, and Morphology in the Classification of Pituitary Neuroendocrine Tumors: the Importance of Routine Analysis of Pituitary Transcription Factors. Endocr Pathol. 2020;31(4):330–336. https://doi.org/10.1007/s12022-020-09646-x.; Liu X, Dai C, Feng M, Li M, Chen G, Wang R. Diagnosis and treatment of refractory pituitary adenomas: a narrative review. Gland Surg. 2021;10(4):1499–1507. https://doi.org/10.21037/gs-20-873.; Akirov A, Asa SL, Amer L, Shimon I, Ezzat S. The Clinicopathological Spectrum of Acromegaly. J Clin Med. 2019;8(11):1962. https://doi.org/10.3390/jcm8111962.; Ferrés A, Reyes L, Di Somma A, Topczewski T, Mosteiro A, Guizzardi G et al. The Prognostic-Based Approach in Growth Hormone-Secreting Pituitary Neuroendocrine Tumors (PitNET): Tertiary Reference Center, Single Senior Surgeon, and Long-Term Follow-Up. Cancers (Basel). 2022;15(1):267. https://doi.org/10.3390/cancers15010267.; Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L et al. A Pituitary Society update to acromegaly management guidelines. Pituitary. 2021;24(1):1–13. https://doi.org/10.1007/s11102-020-01091-7.; Remba-Shapiro I, Nachtigall LB. Treatment of acromegaly with oral octreotide. Best Pract Res Clin Endocrinol Metab. 2024:101888. https://doi.org/10.1016/j.beem.2024.101888.; Puig-Domingo M, Gil J, Sampedro-Nuñez M, Jordà M, Webb SM, Serra G et al. Molecular profiling for acromegaly treatment: a validation study. Endocr Relat Cancer. 2020;27(6):375–389. https://doi.org/10.1530/ERC-18-0565.; Ku CR, Melnikov V, Zhang Z, Lee EJ. Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality? Endocrinol Metab (Seoul). 2020;35(2):206–216. https://doi.org/10.3803/EnM.2020.35.2.206.; Kasuki L, Lamback E, Antunes X, Gadelha MR. Biomarkers of response to treatment in acromegaly. Expert Rev Endocrinol Metab. 2024;19(1):71–80. https://doi.org/10.1080/17446651.2023.2293107.; Găloiu S, Toma ID, Tănasie DI, Bărbulescu A, Baciu I, Niculescu DA et al. High mortality risk among women with acromegaly still persists. Front Endocrinol (Lausanne). 2024;15:1348972. https://doi.org/10.3389/fendo.2024.1348972.; Gil J, Marques-Pamies M, Sampedro M, Webb SM, Serra G, Salinas I et al. Data mining analyses for precision medicine in acromegaly: a proof of concept. Sci Rep. 2022;12(1):8979. https://doi.org/10.1038/s41598-022-12955-2.; Berton AM, Prencipe N, Bertero L, Baldi M, Bima C, Corsico M et al. Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study. J Clin Med. 2022;12(1):25. https://doi.org/10.3390/jcm12010025.; Fleseriu M, Führer-Sakel D, van der Lely AJ, De Marinis L, Brue T, van der Lans-Bussemaker J et al. More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY. Eur J Endocrinol. 2021;185(4):525–538. https://doi.org/10.1530/EJE-21-0239.; Soukup J, Hornychova H, Manethova M, Michalova K, Michnova L, Popovska L et al. Predictive and prognostic significance of tumour subtype, SSTR1-5 and e-cadherin expression in a well-defined cohort of patients with acromegaly. J Cell Mol Med. 2021;25(5):2484–2492. https://doi.org/10.1111/jcmm.16173.; Obari A, Sano T, Ohyama K, Kudo E, Qian ZR, Yoneda A et al. Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocr Pathol. 2008;19(2):82–91. https://doi.org/10.1007/s12022-008-9029-z.; Asa SL, Ezzat S. An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism. J Clin Med. 2021;10(11):2254. https://doi.org/10.3390/jcm10112254.; Kasuki L, Gadelha MR. Innovative therapeutics in acromegaly. Best Pract Res Clin Endocrinol Metab. 2022;36(6):101679. https://doi.org/10.1016/j.beem.2022.101679.; Coopmans EC, Schneiders JJ, El-Sayed N, Erler NS, Hofland LJ, van der Lely AJ et al. T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly. Eur J Endocrinol. 2020;182(6):595–605. https://doi.org/10.1530/EJE-19-0840.; Puig-Domingo M, Resmini E, Gomez-Anson B, Nicolau J, Mora M, Palomera E et al. Magnetic resonance imaging as a predictor of response to somatostatin analogs in acromegaly after surgical failure. J Clin Endocrinol Metab. 2010;95(11):4973–4978. https://doi.org/10.1210/jc.2010-0573.; Kocak B, Durmaz ES, Kadioglu P, Polat Korkmaz O, Comunoglu N, Tanriover N et al. Predicting response to somatostatin analogues in acromegaly: machine learning-based high-dimensional quantitative texture analysis on T2-weighted MRI. Eur Radiol. 2019;29(6):2731–2739. https://doi.org/10.1007/s00330-018-5876-2.; Liu CX, Wang SZ, Heng LJ, Han Y, Ma YH, Yan LF et al. Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics. J Comput Assist Tomogr. 2022;46(1):124–130. https://doi.org/10.1097/RCT.0000000000001249.; Tang Y, Xie T, Guo Y, Liu S, Li C, Liu T et al. Analysis of Diffusion-Weighted and T2-Weighted Imaging in the Prediction of Distinct Granulation Patterns of Somatotroph Adenomas. World Neurosurg. 2024;182:e334–e343. https://doi.org/10.1016/j.wneu.2023.11.107.; Scânteie CL, Leucuţa DC, Ghervan C. The therapeutic response of somatotropinomas according to the T2-weighted signal intensity on the MRI. Med Pharm Rep. 2021;94(4):425–433. https://doi.org/10.15386/mpr-1299.; Анциферов МБ, Петряйкин АВ, Алексеева ТМ, Пронин ЕВ, Хоружая АН, Тамаева СМ. Современные возможности опухоль-ориентированной диагностики и лечения акромегалии. Фарматека. 2023;(3):78–88. https://doi.org/10.18565/pharmateca.2023.3.78-88.; Marques-Pamies M, Gil J, Jordà M, Puig-Domingo M. Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly. Arch Med Res. 2023;54(8):102924. https://doi.org/10.1016/j.arcmed.2023.102924.; Durmuş ET, Atmaca A, Kefeli M, Çalışkan S, Mete O, Aslan K et al. Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study. Growth Horm IGF Res. 2022;67:101502. https://doi.org/10.1016/j.ghir.2022.101502.; Tomasik A, Stelmachowska-Banaś M, Maksymowicz M, Czajka-Oraniec I, Raczkiewicz D, Zieliński G et al. Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly. Front Endocrinol (Lausanne). 2022;13:957301. https://doi.org/10.3389/fendo.2022.957301.; Biagetti B, Iglesias P, Villar-Taibo R, Moure MD, Paja M, Araujo-Castro M et al. Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain. Front Endocrinol (Lausanne). 2022;13:984877. https://doi.org/10.3389/fendo.2022.984877.; Giustina A, di Filippo L, Uygur MM, Frara S. Modern approach to resistant acromegaly. Endocrine. 2023;80(2):303–307. https://doi.org/10.1007/s12020-023-03317-7.; Pronin VS, Antsiferov MB, Alexeeva TM, Pronin EV. Using a Precision Approach to Optimize the Drug Therapy of Patients With Acromegaly Syndrome. In: Ahmad M (ed.). The Pituitary Gland – An Overview of Pathophysiology and Current Management Techniques. London: IntechOpen; 2023, pp. 25–44. https://doi.org/10.5772/intechopen.1001376.; Ezzat S, Caspar-Bell GM, Chik CL, Denis MC, Domingue MÈ, Imran SA et al. Predictive markers for postsurgical medical management of acromegaly: a systematic review and consensus treatment guideline. Endocr Pract. 2019;25(4):379–393. https://doi.org/10.4158/EP-2018-0500.; Ezzat S, Wang R, Pintilie M, Asa SL. FGFR4 polymorphic alleles modulate mitochondrial respiration: A novel target for somatostatin analog action in pituitary tumors. Oncotarget. 2017;8(2):3481–3494. https://doi.org/10.18632/oncotarget.13843.; Chiloiro S, De Marinis L. The immune microenviroment in somatotropinomas: from biology to personalized and target therapy. Rev Endocr Metab Disord. 2023;24(2):283–295. https://doi.org/10.1007/s11154-022-09782-1.; Fougner SL, Lekva T, Borota OC, Hald JK, Bollerslev J, Berg JP. The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response. J Clin Endocrinol Metab. 2010;95(5):2334–2342. https://doi.org/10.1210/jc.2009-2197.; Nishioka H, Haraoka J, Akada K. Fibrous bodies are associated with lower GH production and decreased expression of E-cadherin in GH-producing pituitary adenomas. Clin Endocrinol (Oxf). 2003;59(6):768–772. https://doi.org/10.1046/j.1365-2265.2003.01921.x.; Gil J, Marques-Pamies M, Valassi E, García-Martínez A, Serra G, Hostalot C et al. Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response. Biomedicines. 2022;10(2):460. https://doi.org/10.3390/biomedicines10020460.; Gliga MC, Tătăranu LG, Popescu M, Chinezu L, Paşcanu MI. Immunohistochemical evaluation of biomarkers with predictive role in acromegaly: a literature review. Rom J Morphol Embryol. 2023;64(1):25–33. https://doi.org/10.47162/RJME.64.1.03.; Alhambra-Expósito MR, Ibáñez-Costa A, Moreno-Moreno P, Rivero-Cortés E, Vázquez-Borrego MC, Blanco-Acevedo C et al. Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas. Sci Rep. 2018;8(1):6173. https://doi.org/10.1038/s41598-018-24260-y.; Gatto F, Feelders RA, van der Pas R, Kros JM, Waaijers M, Sprij-Mooij D et al. Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly. J Clin Endocrinol Metab. 2013;98(1):E66–E71. https://doi.org/10.1210/jc.2012-2609.; Wang L, He X, Lu L, Chen L, Peng C, Shao C, Ge R. Clinicopathological Analysis of Densely and Sparsely Granulated Somatotroph Tumors of Pituitary. World Neurosurg. 2024. https://doi.org/10.1016/j.wneu.2024.02.115.; Gadelha MR, Kasuki L. Refractory somatotroph adenomas. Pituitary. 2023;26(3):266–268. https://doi.org/10.1007/s11102-023-01324-5.; https://www.med-sovet.pro/jour/article/view/8273

  12. 12
    Academic Journal

    المصدر: Medical Immunology (Russia); Том 26, № 4 (2024); 717-726 ; Медицинская иммунология; Том 26, № 4 (2024); 717-726 ; 2313-741X ; 1563-0625

    وصف الملف: application/pdf

    Relation: https://www.mimmun.ru/mimmun/article/view/3041/1968; Кузьмич Е.В., Алянский А.Л., Иванова Н.Е., Витрищак А.А., Владовская М.Д., Морозова Е.В., Бондаренко С.Н., Семенова Е.В., Зубаровская Л.С., Афанасьев Б.В. Анализ результатов аллогенной трансплантации гемопоэтических стволовых клеток в зависимости от степени HLA-подбора пациента и неродственного донора // Онкогематология, 2014. № 3. С. 25-31.; Хамаганова Е.Г., Хижинский С.П., Абдрахимова А.Р., Кузьминова Е.П., Леонов Е.А., Покровская О.С., Кузьмина Л.А., Паровичникова Е.Н. Мультилокусные HLA-гаплотипы (A-B-C-DRB1-DRB3/ DRB4/DRB5-DQA1-DQB1-DPA1-DPB1) в семьях больных с назначением к трансплантации аллогенных гемопоэтических стволовых клеток // Медицинская иммунология, 2024. Т. 26, № 2. С. 291-302. doi:10.15789/1563-0625-MHH-2651.; Янкевич Т.Э., Трофимов Ю.Д., Болдырева М.Н., Шубина Е.С., Гольцов А.Ю., Алтухова О.С., Суслова Т.А. Разработка системы «HLA-эксперт» для типирования генов HLA с высоким разрешением методом NFS. Опыт использования // Вестник гематологии, 2018. Т. 14, № 2. С. 56.; Loginova M., Smirnova D., Paramonov I. A Novel HLA-B*57 allele, HLA-B*57:163, was identified by next generation sequencing typing. HLA, 2023, Vol. 101, no. 2, pp. 171-172.; Standards for histocompatibility & immunogenetics testing [date of access March 2024]. Available at: http://www.efiweb.org.; https://www.mimmun.ru/mimmun/article/view/3041

  13. 13
    Academic Journal

    المساهمون: The research was carried out at the expense of the state task (subject registration no. АААА-А21-121012190018-2), Исследование выполнено за счет средств государственного задания (№ регистрации темы АААА-А21- 121012190018-2)

    المصدر: Izvestiya Rossiiskoi Akademii Nauk. Seriya Geograficheskaya; Том 87, № 8 (2023); 1131-1142 ; Известия Российской академии наук. Серия географическая; Том 87, № 8 (2023); 1131-1142 ; 2658-6975 ; 2587-5566

    وصف الملف: application/pdf

    Relation: https://izvestia.igras.ru/jour/article/view/2380/1449; Блануца В.И. Развертывание информационно-коммуникационной сети как географический процесс (на примере становления сетевой структуры сибирской почты). М.: ИНФРА-М, 2016. 246 с.; Блануца В.И. Информационно-сетевая география. М.: ИНФРА-М, 2019. 243 с.; Блануца В.И. Географическая экспертиза стратегий экономического развития России. М.: ИНФРА-М, 2021. 198 с.; Блануца В.И. Общественная география: цифровые приоритеты XXI века. М.: ИНФРА-М, 2022. 252 с.; Герасимов И.П. Советская конструктивная география: задачи, подходы, результаты. М.: Наука, 1976. 208 с.; Грицай О.В., Иоффе Г.В., Трейвиш А.И. Центр и периферия в региональном развитии. М.: Наука, 1991. 168 с.; Космачев К.П. Пионерное освоение тайги (экономико-географические проблемы). Новосибирск: Наука, 1974. 144 с.; Космачев К.П. Географическая экспертиза (методологические аспекты). Новосибирск: Наука, 1981. 109 с.; Никульников Ю.С. Оценка хозяйственной освоенности территории – анализ, новые принципы конструкции показателя // Доклады Института географии Сибири и Дальнего Востока. Иркутск, 1976. Вып. 50. С. 27–36.; Тархов С.А. Эволюционная морфология транспортных сетей. Смоленск–М.: Изд-во “Универсум”, 2005. 384 с.; Agarwal A., Mohanta C., Misra G. Principle of 6G wireless networks: Vision, challenges and applications // J. Information Technology and Digital World. 2021. Vol. 3 (4). P. 243–258.; Akyildiz I.F., Guo H. Holographic-type communication: A new challenge for the next decade // ITU J. on Future and Evolving Technologies. 2022. Vol. 3 (2). P. 421–442.; Amoore L. Cloud geographies: Computing, data, sovereignty // Progress in Human Geography. 2018. Vol. 42 (1). P. 4–24.; Atkins E. Tracing the “cloud”: Emergent political geographies of global data centers // Political Geography. 2021. Vol. 86. P. 102306.; Barroso J.L.G., Martínez J.P. The geography of the digital divide: Broadband deployment in the Community of Madrid // Universal Access in the Information Society. 2004. Vol. 3 (3). P. 264–271.; Bassoli R., Boche H., Deppe C., Ferrara R., Fitzek F.H.P., Janssen G., Saeedinaeeni S. Quantum Communication Networks. Cham: Springer, 2021. 229 p.; Calabrese A. The periphery in the center: The information age and the “good life” in rural America // Int. Communication Gazette. 1991. Vol. 48 (2). P. 195–128.; Chiwhane J.A., Yadav L.N., Rakhade V.M. A review of future mobile technologies and 4G, 5G, 6G, 7G // Int. J. of Advanced Research in Computer and Communication Engineering. 2022. Vol. 11 (12). P. 84–90.; Dziembała M., Talar S. The role of ICT in smart specialization of EU regions // J. Business Economics and Management. 2021. Vol. 22 (6). P. 1512–1530.; Fard A. Cloudy landscapes: On the extended geography smart urbanism // Telematics and Informatics. 2020. Vol. 55. P. 101450.; Flaherty E., Sturm T., Farries E. The conspiracy of Covid-19 and 5G: Spatial analysis fallacies in the age of data democratization // Social Science & Medicine. 2022. Vol. 293. P. 114546.; Grujić N., Brdar S., Osinga S., Hofstede G.J., Athanasiadis I.N., Pljakić M., Obrenović N., Govedarica M., Crnojević V. Combining telecom data with heterogeneous data sources for traffic and emission assessments – An agent-based approach // Int. J. Geo-Information. 2022. Vol. 11. P. 366.; Hägerstrand T. Innovation Diffusion as a Spatial Process. Chicago: The Univ. of Chicago, 1967. 350 p.; Islam M.M., Ramezani F., Lu H.Y., Naderpour M. Optimal placement of applications in the fog environment: A systematic literature review // J. of Parallel and Distributed Computing. 2023. Vol. 174. P. 46–69.; Kellerman A. Telecommunications and the geography of metropolitan areas // Progress in Human Geography. 1984. Vol. 8 (2). P. 222–246.; Kim H., O’Kelly M.E. Reliable p-hub location problems in telecommunication networks // Geographical Analysis. 2009. Vol. 41 (3). P. 283–306.; Kourtit K., Nijkamp P. Smart cities in smart space: A regional science perspective // Scienze Regionali. Italian J. Regional Science. 2018. Vol. 17 (1). P. 105–114.; Li M., Gao S., Lu F., Liu K., Zhang H., Tu W. Prediction of human activity intensity using the interactions in physical and social spaces through graph convolutional networks // Int. J. Geographical Information Science. 2021. Vol. 35 (12). P. 2489–2516.; Lu Y., Zheng X. 6G: A survey on technologies, scenarios, challenges, and the related issues // J. Industrial Information Integration. 2020. Vol. 19. P. 100158.; Malecki E.J. The economic geography of the internet’s infrastructure // Economic Geography. 2002. Vol. 78 (4). P. 399–424.; Mehta P.L., Kumar A., Mohammad B., Prasad R. A technological and business perspective on connected drones for 6G and beyond mobile wireless communications // Wireless Personal Communications. 2022. Vol. 127. P. 2605–2624.; Morandi C., Rolando A., di Vita S. From Smart City to Smart Region: Digital Services for an Internet of Places. Milan: Springer–Verlag, 2016. 103 p.; Navio-Marco J., Rodrigo-Moya B., Gerli P. The rising importance of the “Smart territory” concept: Definition and implications // Land Use Policy. 2020. Vol. 99 (1). P. 105003.; Oughton E.J., Frias Z. The cost, coverage and rollout implications of 5G infrastructure in Britain // Telecommunications Policy. 2018. Vol. 42 (8). P. 636–652.; Oughton E.J., Russell T. The importance of spatio-temporal infrastructure assessment: Evidence for 5G from the Oxford-Cambridge arc // Computer, Environment and Urban Systems. 2020. Vol. 83. P. 101515.; Saunavaara J., Salminen M. Geography of the global submarine fiber-optic cable network: The case for Arctic Ocean solutions // Geographical Review. 2023. Vol. 113 (1). P. 1–19.; Sawada M., Cossette D., Wellar B., Kurt T. Analysis of the urban/rural broadband divide in Canada: Using GIS in planning terrestrial wireless deployment // Government Information Quarterly. 2006. Vol. 23 (3–4). P. 454–479.; Shoewu O., Akinyemi L.A., Ayangbekun O.J. Insights into the development trends in 7G mobile wireless networks // J. Advancement in Engineering and Technology. 2020. Vol. 8 (1). P. 1–4.; Stewart J., Nickerson C. Costs and benefits of 5G geographical coverage in Europe. Cambridge, UK: Analysis Mason Ltd., 2021. 20 p.; Van Dijk J. The Digital Divide. Cambridge: Polity Press, 2020. 208 p.; Wenzlhuemer R. The dematerialization of telecommunication: Communication centers and peripheries in Europe and the world, 1850–1920 // J. Global History. 2007. Vol. 2 (3). P. 345–372.; Werner P.A., Porczek M. Spatial patterns of development of mobile technologies for 5G networks // Computational Science and Its Applications – ICCSA 2019. Cham: Springer, 2019. P. 448–459.; Ye N., Yu J., Wang A., Zhang R. Help from space: Grant-free massive access for satellite-based IoT in the 6G era // Digital Communications and Networks. 2022. Vol. 8 (2). P. 215–224.; Zhu Y. Tactile communication: Making communication technology warmer and more emotional // Proceedings of the 5th International Conference on Information Science and Systems. Beijing: Association for Computing Machinery, 2022. P. 43–48.; Zong B., Fan C., Wang X., Duan X., Wang B., Wang J. 6G technologies: Key drivers, core requirements, system architectures, and enabling technologies // IEEE Vehicular Technology Magazine. 2019. Vol. 14 (3). P. 18–27.; https://izvestia.igras.ru/jour/article/view/2380

  14. 14
    Academic Journal

    المساهمون: The study was supported by the Russian Science Foundation (Grant No. 23-64-00002)., Работа выполнена при поддержке Российского научного фонда (грант № 23-64-00002).

    المصدر: Biological Products. Prevention, Diagnosis, Treatment; Том 24, № 2 (2024): Высокотехнологичные лекарственные препараты; 215-228 ; БИОпрепараты. Профилактика, диагностика, лечение; Том 24, № 2 (2024): Высокотехнологичные лекарственные препараты; 215-228 ; 2619-1156 ; 2221-996X

    وصف الملف: application/pdf

    Relation: https://www.biopreparations.ru/jour/article/view/582/864; https://www.biopreparations.ru/jour/article/view/582/839; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/903; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/954; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/955; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/956; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/957; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/958; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/959; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/960; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/961; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/962; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/963; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/964; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/965; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/966; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/972; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/977; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/978; https://www.biopreparations.ru/jour/article/downloadSuppFile/582/992; Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18(5):358–78. https://doi.org/10.1038/s41573-019-0012-9; Srivastava A. In vivo tissue-tropism of adeno-associated viral vectors. Curr Opin Virol. 2016;21:75–80. https://doi.org/10.1016/j.coviro.2016.08.003; Pañeda A, Vanrell L, Mauleon I, Crettaz JS, Berraondo P, Timmermans EJ, et al. Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders. Hum Gene Ther. 2009;20(8):908–17. https://doi.org/10.1089/hum.2009.031; Hauck B, Xiao W. Characterization of tissue tropism determinants of adeno-associated virus type 1. J Virol. 2003;77(4):2768–74. https://doi.org/10.1128/jvi.77.4.2768-2774.2003; Han J, Zhu L, Zhang J, Guo L, Sun X, Huang C, et al. Rational engineering of adeno-associated virus capsid enhances human hepatocyte tropism and reduces immunogenicity. Cell Prolif. 2022;55(12):e13339. https://doi.org/10.1111/cpr.13339; Li C, Samulski RJ. Engineering adeno-associated virus vectors for gene therapy. Nat Rev Genet. 2020;21(4):255–72. https://doi.org/10.1038/s41576-019-0205-4; Rode L, Bär C, Groß S, Rossi A, Meumann N, Viereck J, et al. AAV capsid engineering identified two novel variants with improved in vivo tropism for cardiomyocytes. Mol Ther. 2022;30(12):3601–18. https://doi.org/10.1016/j.ymthe.2022.07.003; Ghauri MS, Ou L. AAV engineering for improving tropism to the central nervous system. Biology (Basel). 2023;12(2):186. https://doi.org/10.3390/biology12020186; Drouyer M, Chu TH, Labit E, Haase F, Navarro RG, Nazareth D, et al. Novel AAV variants with improved tropism for human Schwann cells. Mol Ther Methods Clin Dev. 2024;32(2):101234. https://doi.org/10.1016/j.omtm.2024.101234; Gigout L, Rebollo P, Clement N, Warrington KH, Muzyczka N, Linden RM, et al. Altering AAV tropism with mosaic viral capsids. Mol Ther. 2005;11(6):856–65. https://doi.org/10.1016/j.ymthe.2005.03.005; Wu Z, Asokan A, Grieger JC, Govindasamy L, AgbandjeMcKenna M, Samulski RJ. Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes. J Virol. 2006;80(22):11393–7. https://doi.org/10.1128/jvi.01288-06; Asokan A, Conway JC, Phillips JL, Li C, Hegge J, Sinnott R, et al. Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle. Nat Biotechnol. 2010;28(1):79–82. https://doi.org/10.1038/nbt.1599; Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA. 2002;99(18):11854–9. https://doi.org/10.1073/pnas.182412299; Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, Zhou X, et al. Clades of adeno-associated viruses are widely disseminated in human tissues. J Virol. 2004;78(12):6381–8. https://doi.org/10.1128/jvi.78.12.6381-6388.2004; Zinn E, Pacouret S, Khaychuk V, Turunen HT, Carvalho LS, Andres-Mateos E, et al. In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector. Cell Rep. 2015;12(6):1056–8. https://doi.org/10.1016/j.celrep.2015.07.019; Szumska J, Grimm D. Boosters for adeno-associated virus (AAV) vector (r)evolution. Cytotherapy. 2023;25(3):254–60. https://doi.org/10.1016/j.jcyt.2022.07.005; Adachi K, Enoki T, Kawano Y, Veraz M, Nakai H. Drawing a high-resolution functional map of adeno-associated virus capsid by massively parallel sequencing. Nat Commun. 2014;5:3075. https://doi.org/10.1038/ncomms4075; Marsic D, Govindasamy L, Currlin S, Markusic DM, Tseng YS, Herzog RW, et al. Vector design Tour de Force: integrating combinatorial and rational approaches to derive novel adeno-associated virus variants. Mol Ther. 2014;22(11):1900–9. https://doi.org/10.1038/mt.2014.139; Weinmann J, Weis S, Sippel J, Tulalamba W, Remes A, El Andari J, et al. Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants. Nat Commun. 2020;11(1):5432. https://doi.org/10.1038/s41467-020-19230-w; Grimm D, Lee JS, Wang L, Desai T, Akache B, Storm TA, et al. In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. J Virol. 2008;82(12):5887–911. https://doi.org/10.1128/jvi.00254-08; Li H. Minimap2: Pairwise alignment for nucleotide sequences. Bioinformatics. 2018;34(18):3094–3100. https://doi.org/10.1093/bioinformatics/bty191; Cock PJA, Antao T, Chang JT, Chapman BA, Cox CJ, Dalke A, et al. Biopython: Freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics. 2009;25(11):1422–3. https://doi.org/10.1093/bioinformatics/btp163; https://www.biopreparations.ru/jour/article/view/582

  15. 15
    Academic Journal
  16. 16
    Conference

    المؤلفون: Мусхарина, Ю. Ю.

    وصف الملف: application/pdf

    Relation: Инновационные процессы на производстве и в профессиональном образовании: проблемы формирования кадрового потенциала предприятий и образовательного пространства для рабочей и учащейся молодежи : материалы VI Международной научно-практической конференции. — Екатеринбург, 2013; Мусхарина, Ю. Ю. Значение и роль физической культуры в формировании духовных качеств будущего учителя / Ю. Ю. Мусхарина // Инновационные процессы на производстве и в профессиональном образовании: проблемы формирования кадрового потенциала предприятий и образовательного пространства для рабочей и учащейся молодежи : материалы VI Международной научно-практической конференции, 17–18 апреля 2012 г., г. Первоуральск. — Первоуральск : Филиал РГППУ в г. Первоуральск, 2012. — С. 121-124.; https://elar.rsvpu.ru/handle/123456789/43455

  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal